3rd Quarter - Report

ARNOLD & PORTER KAYE SCHOLER LLP for ESTEVE PHARMACEUTICALS, LLC

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to reimbursement and coverage for certain drugs.

Foreign entity interest: Esteve Pharmaceuticals, LLC is ultimately owned by Esteve Healthcare, S.L., Grupo Esteve Lifesciences, S.L., and Lubea Cataman GmbH & Co. KG, all of whom may have an interest in the lobbying activity disclosed herein.

LobbyistCovered position, as disclosed
BOBBY MCMILLIN —

Contacted: Centers For Medicare and Medicaid Services (CMS)

Medicare/Medicaid MMM

Issues related to reimbursement and coverage for certain drugs.

Foreign entity interest: Esteve Pharmaceuticals, LLC is ultimately owned by Esteve Healthcare, S.L., Grupo Esteve Lifesciences, S.L., and Lubea Cataman GmbH & Co. KG, all of whom may have an interest in the lobbying activity disclosed herein.

LobbyistCovered position, as disclosed
BOBBY MCMILLIN —

Contacted: Centers For Medicare and Medicaid Services (CMS)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
ESTEVE PHARMACEUTICALS, S.A. Spain Spain 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.